Pharma Journalist 8791 posts 0 comments

The Blood-Brain Barrier Drug Delivery Summit, or B3DD, will be held in Boston, MA, from August 13-15, 2019. This new Hanson Wade event is aimed at experts looking to deliver CNS drug…
Read More...

Nexus Pharmaceuticals Inc., woman-owned, privately held, US-based healthcare company, announced an agreement with the village of Pleasant Prairie, Wisconsin to build an industry-leading…
Read More...

Jazz Pharmaceuticals plc announced that the company has signed a definitive agreement under which Jazz has acquired Redx Pharma's (Redx) pan-RAF inhibitor program for the potential…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for isatuximab for the treatment of patients with relapsed/refractory…
Read More...

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has introduced a new sealing solution for tamper-proof closure of…
Read More...

Ligand Pharmaceuticals Incorporated announced positive top line results from a Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol program. The CE-Iohexol program was…
Read More...

Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with autoimmune diseases and cancer, announced a collaboration with…
Read More...

MacroGenics, Inc. and I-Mab Biopharma (I-Mab) announced that the companies have entered into an exclusive collaboration and license agreement to develop and commercialize enoblituzumab.…
Read More...

Catalent, Inc. announced that it has significantly expanded the capacity of its global spray drying operations through an agreement with Sanofi Active Ingredient Solutions, an…
Read More...

ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering off-target toxicity and linker stability assay…
Read More...